CircTIMELESS regulates the proliferation and invasion of lung squamous cell carcinoma cells via the miR-136-5p/ROCK1 axis
- PMID: 31960961
- DOI: 10.1002/jcp.29521
CircTIMELESS regulates the proliferation and invasion of lung squamous cell carcinoma cells via the miR-136-5p/ROCK1 axis
Abstract
Numerous studies demonstrate that circular RNAs (circRNAs) are critical regulators of the occurrence and progression of tumors. However, research on the involvement of circRNAs in lung squamous cell carcinoma (LUSC) is limited. In our study, circTIMELESS (also named hsa_circ_0000408 in the Human circRNA Database) was upregulated in both LUSC tissues and LUSC cells, and circTIMELESS expression was positively associated with the TNM stage. Moreover, circTIMELESS silencing markedly suppressed invasion in vitro and disrupted proliferation in vitro as well as in vivo. Additional investigations have shown that circTIMELESS functions as a miR-136-5p "sponge" and regulates miR-136-5p expression. Furthermore, the impact of miR-136-5p upregulation was consistent with the results of circTIMELESS silencing, both of which inhibited the proliferation and invasion of LUSC cells. Additional results showed that Rho-associated coiled-coil containing protein kinase 1 (ROCK1) is targeted by miR-136-5p. The results of recovery experiments showed that ROCK1 overexpression partly rescued the impact of circTIMELESS silencing and miR-136-5p upregulation on proliferation and invasion. Consequently, our findings confirmed that circTIMELESS exists in LUSC and acts as a tumor promoter through the miR-136-5p/ROCK1 axis. Based on these findings, circTIMELESS may be potentially utilized as a therapeutic target for LUSC.
Keywords: ROCK1; circTIMELESS; lung squamous cell carcinoma; miR-136-5p.
© 2020 Wiley Periodicals, Inc.
Similar articles
-
Circ-E2F3 acts as a ceRNA for miR-204-5p to promote proliferation, metastasis and apoptosis inhibition in retinoblastoma by regulating ROCK1 expression.Exp Mol Pathol. 2021 Jun;120:104637. doi: 10.1016/j.yexmp.2021.104637. Epub 2021 Apr 18. Exp Mol Pathol. 2021. PMID: 33844975
-
Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis.Respir Res. 2021 Sep 18;22(1):248. doi: 10.1186/s12931-021-01840-7. Respir Res. 2021. PMID: 34537072 Free PMC article.
-
H3K27ac-activated LINC00519 promotes lung squamous cell carcinoma progression by targeting miR-450b-5p/miR-515-5p/YAP1 axis.Cell Prolif. 2020 May;53(5):e12797. doi: 10.1111/cpr.12797. Epub 2020 Apr 16. Cell Prolif. 2020. PMID: 32297697 Free PMC article.
-
CircRNAs in Lung-intestinal Axis Cancer.Curr Mol Med. 2021;21(4):291-299. doi: 10.2174/1566524020999200831122219. Curr Mol Med. 2021. PMID: 32867635 Review.
-
Implication of non-coding RNA-mediated ROCK1 regulation in various diseases.Front Mol Biosci. 2022 Sep 13;9:986722. doi: 10.3389/fmolb.2022.986722. eCollection 2022. Front Mol Biosci. 2022. PMID: 36177350 Free PMC article. Review.
Cited by
-
Landscape of circular RNAs in different types of lung cancer and an emerging role in therapeutic resistance (Review).Int J Oncol. 2023 Feb;62(2):21. doi: 10.3892/ijo.2022.5469. Epub 2022 Dec 23. Int J Oncol. 2023. PMID: 36562354 Free PMC article.
-
PVT1/miR-136/Sox2/UPF1 axis regulates the malignant phenotypes of endometrial cancer stem cells.Cell Death Dis. 2023 Mar 3;14(3):177. doi: 10.1038/s41419-023-05651-0. Cell Death Dis. 2023. PMID: 36869031 Free PMC article.
-
lncRNA MIR4435‑2HG promotes the progression of liver cancer by upregulating B3GNT5 expression.Mol Med Rep. 2022 Jan;25(1):38. doi: 10.3892/mmr.2021.12554. Epub 2021 Dec 3. Mol Med Rep. 2022. PMID: 34859256 Free PMC article.
-
The miR-136-5p/ROCK1 axis suppresses invasion and migration, and enhances cisplatin sensitivity in head and neck cancer cells.Exp Ther Med. 2021 Apr;21(4):317. doi: 10.3892/etm.2021.9748. Epub 2021 Feb 3. Exp Ther Med. 2021. PMID: 33717260 Free PMC article.
-
Regulation of ROCK1/2 by long non-coding RNAs and circular RNAs in different cancer types.Oncol Lett. 2022 May;23(5):159. doi: 10.3892/ol.2022.13279. Epub 2022 Mar 22. Oncol Lett. 2022. PMID: 35399329 Free PMC article. Review.
References
REFERENCES
-
- Barrett, S. P., Wang, P. L., & Salzman, J. (2015). Circular RNA biogenesis can proceed through an exon-containing lariat precursor. eLife, 4, 1-18. https://doi.org/10.7554/eLife.07540
-
- Chen, W., Yang, Y., Chen, B., Lu, P., Zhan, L., Yu, Q., … Li, Q. (2014). MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells. Journal of Neuro-Oncology, 120, 43-53. https://doi.org/10.1007/s11060-014-1535-x
-
- Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., … He, J. (2016). Cancer statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. https://doi.org/10.3322/caac.21338
-
- Coudray, N., Ocampo, P. S., Sakellaropoulos, T., Narula, N., Snuderl, M., Fenyö, D., … Tsirigos, A. (2018). Classification and mutation prediction from nonsmall cell lung cancer histopathology images using deep learning. Nature Medicine (New York, NY, United States), 24, 1559-1567. https://doi.org/10.1038/s41591-018-0177-5
-
- Cui, G., Cui, M., Li, Y., Liang, Y., Li, W., Guo, H., & Zhao, S. (2014). MiR-186 targets ROCK1 to suppress the growth and metastasis of NSCLC cells. Tumour Biology, 35, 8933-8937. https://doi.org/10.1007/s13277-014-2168-6
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical